Vivimed Labs Faces Scrutiny: SBI Alleges Financial Irregularities, CBI Notices CFO & CS

Vivimed Labs Ltd, a Hyderabad-based pharmaceutical and specialty chemicals firm, is embroiled in a fresh probe after SBI lodged a complaint with CBI's Bank Security & Fraud Branch. The lender accuses the company of financial irregularities tied to a ₹184 crore term loan availed for business operations.

The case mirrors probes into Vibha Agrotech (₹177 Cr) and Neeta Chemicals (₹533 Cr), totaling ₹894 Cr in alleged bank frauds. CBI invoked IPC sections for conspiracy, cheating, forgery, and account falsification.
​
This escalates Vivimed's woes amid prior forensic audits, NPA status, and insolvency proceedings.

Key Highlights

• Alleged Fraud Amount: ₹184 Cr loan from SBI Hyderabad; diverted/falsified.
• ​Accused: MD Santosh Varalwar, directors Sandeep, Manohar Rao, Subash Varalwar; CFO/CS notices issued.
• CBI Charges: IPC 120B, 420, 468, 471, 477A (conspiracy, cheating, forgery).
• ​Context: Part of ₹894 Cr cases; company in stressed assets recovery.

Sources: Deccan Chronicle, Facebook/Deccan News, Business Standard.